VEGFA and neoplasm: Further studies focusing on VEGFR-2-dependent pro-tumorigenic and vasculogenic interactions of GSLCs with VEGF-producing malignant or nonmalignant host cells in the tumor microenvironment will provide insight into the mechanistic basis of tumor development and therapy design.